Table 1 Characteristic of study population by quartiles of total testosterone (men, n = 1782)
Characteristic | Total testosterone (nmol/L) | P for trend | |||
|---|---|---|---|---|---|
Q1 (≤10.75) | Q2 (10.76–14.06) | Q3 (14.07–17.88) | Q4 (≥17.89) | ||
Men | |||||
 N | 445 | 447 | 447 | 443 |  |
 Age, year | 67.94 ± 9.64 | 67.16 ± 9.07 | 67.66 ± 8.13 | 68.93 ± 8.17 | 0.043 |
 Duration of diabetes, year | 9.64 ± 8.05 | 10.35 ± 7.89 | 9.80 ± 7.16 | 11.87 ± 8.50 | <0.001 |
 Current smoke, % | 30.2 | 35.8 | 35.3 | 32.3 | 0.683 |
 Platelet count, *109/L | 202.94 ± 52.40 | 204.43 ± 55.97 | 199.82 ± 54.54 | 195.59 ± 53.93 | 0.018 |
 Albumin, g/dl | 45.02 ± 2.59 | 44.81 ± 2.64 | 44.53 ± 2.68 | 44.24 ± 2.98 | <0.001 |
 AST/ALT | 1.07 ± 0.41 | 1.09 ± 0.38 | 1.12 ± 0.35 | 1.22 ± 0.49 | <0.001 |
 BMI, kg/m2 | 26.25 ± 3.39 | 25.68 ± 3.36 | 24.72 ± 2.80 | 23.36 ± 2.93 | <0.001 |
 Waist circumference, cm | 96.10 ± 8.93 | 94.05 ± 9.38 | 91.53 ± 7.62 | 87.41 ± 8.24 | <0.001 |
 FPG, mmol/L | 8.20 ± 2.51 | 7.84 ± 2.46 | 7.65 ± 2.16 | 7.64 ± 2.21 | <0.001 |
 HbA1c, % | 7.73 ± 1.38 | 7.65 ± 1.40 | 7.55 ± 1.39 | 7.57 ± 1.54 | 0.062 |
 SBP, mmHg | 146.74 ± 19.44 | 144.99 ± 18.91 | 142.99 ± 18.92 | 141.65 ± 19.64 | <0.001 |
 DBP, mmHg | 80.73 ± 11.60 | 80.40 ± 10.89 | 80.44 ± 11.25 | 77.86 ± 10.22 | <0.001 |
 Total cholesterol, mmol/L | 4.80 ± 1.19 | 4.72 ± 1.06 | 4.77 ± 1.03 | 4.90 ± 1.03 | 0.084 |
 Triglycerides, mmol/L | 2.29 ± 2.00 | 1.87 ± 1.42 | 1.70 ± 1.03 | 1.42 ± 0.92 | <0.001 |
 HDL-C, mmol/L | 1.05 ± 0.22 | 1.06 ± 0.22 | 1.09 ± 0.23 | 1.22 ± 0.29 | <0.001 |
 LDL-C, mmol/L | 2.96 ± 0.83 | 2.96 ± 0.78 | 2.99 ± 0.77 | 3.05 ± 0.76 | 0.068 |
 Hypertension, % | 84.7 | 80.1 | 77.4 | 73.1 | <0.001 |
 Dyslipidemia, % | 72.1 | 71.8 | 64.2 | 49.0 | <0.001 |
 Simple NAFLD, % | 16.6 | 19.2 | 20.4 | 19.6 | <0.001 |
 Probable NASH, % | 67.4 | 55.3 | 45.2 | 28.2 | <0.001 |
 NFS | − 0.13 ± 0.99 | − 0.18 ± 1.05 | − 0.13 ± 0.96 | − 0.06 ± 1.04 | 0.200 |
 Probable NAFLD fibrosis, % | 15.8 | 19.1 | 20.3 | 24.4 | 0.161 |